Dai Zhenhua, Liu Zhiqiang, Xiu Bingshui, Yang Xiqin, Zhao Ping, Zhang Xuhui, Duan Cuimi, Que Haiping, Zhang Heqiu, Feng Xiaoyan
Department of Bio-diagnosis, Beijing Institute of Basic Medical Sciences, 27 Taiping Road, Beijing 100850, China.
Chaoyang District Centre for Disease Control and Prevention, 25 Panjiayuan Huaweili, Beijing 100029, China.
Iran J Basic Med Sci. 2017 Apr;20(4):360-367. doi: 10.22038/IJBMS.2017.8575.
Detection of circulating () antigens is promising in Tuberculosis (TB) diagnosis. However, not a single antigen marker has been found to be widely expressed in all TB patients. This study is aimed to prepare broadly reactive polyclonal antibodies targeting multiple antigen markers (multi-target antibodies) and evaluate their efficacies in TB diagnosis.
A fusion gene consisting of 38kD, ESAT6, and CFP10 was constructed and overexpressed. The fusion polyprotein was used as an immunogen to elicit production of multi-target antibodies. Their reactivities were tested. Then, the multi-target antibodies and three corresponding antibodies elicited by each single antigen (mono-target antibodies) were evaluated with sandwich ELISA for detecting antigens. Their diagnostic efficacies for TB were also compared.
The polyprotein successfully elicited production of multi-target antibodies targeting 38kD, ESAT6, and CFP10 as analyzed by Western blotting. When used as coating antibodies, the multi-target antibodies were more efficient in capturing the three antigens than the corresponding mono-target antibodies. By testing clinical serum, the multi-target antibodies demonstrated significantly higher sensitivity for clinical TB diagnosis than all three mono-target antibodies.
The multi-target antibodies allowed detecting multiple antigens simultaneously and significantly enhanced TB detection compared to routine mono-target antibodies. Our study may provide a promising strategy for TB diagnosis.
检测循环中的()抗原在结核病(TB)诊断中具有前景。然而,尚未发现单一抗原标志物能在所有TB患者中广泛表达。本研究旨在制备针对多种抗原标志物的广谱反应性多克隆抗体(多靶点抗体),并评估其在TB诊断中的效能。
构建并过表达由38kD、ESAT6和CFP10组成的融合基因。融合多蛋白用作免疫原以引发多靶点抗体的产生。测试它们的反应性。然后,用夹心ELISA评估多靶点抗体和由每种单一抗原引发的三种相应抗体(单靶点抗体)检测()抗原的能力。还比较了它们对TB的诊断效能。
通过蛋白质印迹分析,多蛋白成功引发了针对38kD、ESAT6和CFP10的多靶点抗体的产生。当用作包被抗体时,多靶点抗体在捕获这三种抗原方面比相应的单靶点抗体更有效。通过检测临床血清,多靶点抗体对临床TB诊断的敏感性明显高于所有三种单靶点抗体。
与常规单靶点抗体相比,多靶点抗体能够同时检测多种抗原,并显著提高TB检测能力。我们的研究可能为TB诊断提供一种有前景的策略。